SCHEMBL4158550

SCHEMBL4158550

CN(C(=O)N(C(=O)c1c(F)cccc1F)C1CC1)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 4/20 0.33
RAB9A P51151 1/20 0.33
TLR7 Q9NYK1 1/20 0.32
PDK2 Q15119 4/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ALDH1A1 P00352 1/20 0.31
DRD2 P14416 1/20 0.31
GPBAR1 Q8TDU6 2/20 0.31
TSHR P16473 2/20 0.31
RORA P35398 1/20 0.31
RORB Q92753 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4158063 0.95 ALDH1A1 (0.36) RORCRAB9ATLR7PDK2DDB1
SCHEMBL4153945 0.93 RORC (0.31) RORCTLR7ALDH1A1MAPK1
SCHEMBL4154435 0.85 RORC (0.36) RORCTLR7TDP1GPBAR1TSHR
SCHEMBL4154533 0.84 RORC (0.32) RORCRAB9APDK2DDB1CRBN
SCHEMBL4154572 0.83 RORC (0.34) RORCTLR7TDP1GPBAR1TSHR
SCHEMBL4156743 0.83 RORC (0.35) RORCTLR7TDP1GPBAR1TSHR
SCHEMBL4144806 0.82 RORC (0.35) RORCTLR7TDP1GPBAR1TSHR
SCHEMBL4142611 0.82 RORC (0.35) RORCTLR7TDP1GPBAR1TSHR
SCHEMBL4157996 0.82 RORC (0.35) RORCTLR7TDP1TSHRRORA
SCHEMBL4142621 0.81 HDAC6 (0.33) RORCRAB9ATDP1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 RORC 4448/4885RAB9A 642/4885TLR7 905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.